• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人阻塞性肺病的三种表型。

Three phenotypes of obstructive lung disease in the elderly.

机构信息

Department of Pulmonary and Critical Care Medicine & Clinical Research Center for Chronic Obstructive Airway Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

出版信息

Int J Tuberc Lung Dis. 2010 Nov;14(11):1481-8.

PMID:20937191
Abstract

SETTING

Eleven referring hospitals in South Korea.

OBJECTIVE

To classify the phenotypes in elderly subjects with obstructive lung disease (OLD).

METHODS

We analysed 191 subjects aged ≥ 60 years with chronic respiratory symptoms and either obstructive spirometry or bronchial hyperresponsiveness. Factor analysis was performed using commonly measured variables and revealed four significant variables: 1) the ratio of inspiratory capacity to total lung capacity, 2) the total score on the St George's Respiratory Questionnaire, 3) the volume fraction of the lung less than 950 Hounsfield Unit at full inspiration on volumetric computed tomography and 4) post-bronchodilator forced expiratory volume in 1 second (FEV(1)) changes. We performed a cluster analysis on these four variables.

RESULTS

The mean age was 68.5 (± 5.2 SD) years and the mean post-bronchodilator FEV(1) was 52.4% (± 16.5) predicted. Three clusters with the following phenotypes were identified: Cluster 1 included subjects with moderate to severe airflow obstruction and bronchodilator reversibility; Cluster 2 subjects had moderate airflow obstruction without bronchodilator reversibility, and Cluster 3 subjects had severe airflow obstruction without bronchodilator reversibility.

CONCLUSIONS

We identified three phenotypes in elderly subjects with OLD. Follow-up studies are needed to explore the clinical significance of each phenotype.

摘要

背景

韩国的 11 家指定医院。

目的

对老年阻塞性肺疾病(OLD)患者的表型进行分类。

方法

我们分析了 191 名年龄≥60 岁、有慢性呼吸系统症状且存在阻塞性肺功能检查或支气管高反应性的患者。使用常用测量变量进行因子分析,揭示了四个显著变量:1)吸气量与肺总量之比,2)圣乔治呼吸问卷总评分,3)全肺 CT 吸气时低于 950 亨氏单位的肺容积分数,4)支气管扩张剂后 1 秒用力呼气量(FEV1)变化。我们对这四个变量进行了聚类分析。

结果

患者平均年龄为 68.5(±5.2 SD)岁,支气管扩张剂后 FEV1 平均为预测值的 52.4%(±16.5)。确定了三种具有以下表型的聚类:聚类 1 包括中重度气流阻塞和支气管扩张剂逆转的患者;聚类 2 患者有中度气流阻塞但无支气管扩张剂逆转,聚类 3 患者有严重气流阻塞但无支气管扩张剂逆转。

结论

我们在老年 OLD 患者中确定了三种表型。需要进行随访研究以探讨每种表型的临床意义。

相似文献

1
Three phenotypes of obstructive lung disease in the elderly.老年人阻塞性肺病的三种表型。
Int J Tuberc Lung Dis. 2010 Nov;14(11):1481-8.
2
Diagnosing obstructive lung disease. Why is differentiating COPD from asthma important?诊断阻塞性肺疾病。为什么区分慢性阻塞性肺疾病(COPD)和哮喘很重要?
Postgrad Med. 1994 Jun;95(8):69-70, 75-8, 83-5.
3
[Diagnosis of bronchial asthma and chronic obstructive lung disease by the family physician. Ad hoc consensus group 'Diagnosis of asthma/chronic obstructive lung disease by the family physician'].家庭医生对支气管哮喘和慢性阻塞性肺疾病的诊断。“家庭医生对哮喘/慢性阻塞性肺疾病的诊断”特设共识小组
Ned Tijdschr Geneeskd. 1995 Sep 30;139(39):1966-71.
4
Preliminary study of the effects of postoperative methylprednisolone therapy on lung function recovery in patients with chronic obstructive pulmonary disease.术后甲泼尼龙治疗对慢性阻塞性肺疾病患者肺功能恢复影响的初步研究
Clin Pharm. 1989 Mar;8(3):214-9.
5
[Importance of spasm and way of reactivity to bronchodilatator of patients with chronic obstructive pulmonary disease (author's transl)].[慢性阻塞性肺疾病患者痉挛的重要性及对支气管扩张剂的反应方式(作者译)]
Plucne Bolesti Tuberk. 1981 Jan-Mar;33(1):8-13.
6
Impact of spirometry on the management of chronic obstructive airway disease.肺量计对慢性阻塞性气道疾病管理的影响。
J Fam Pract. 1983 Feb;16(2):271-5.
7
A 56-year-old woman with mixed obstructive and restrictive lung disease.一名患有阻塞性和限制性混合性肺病的56岁女性。
Respir Care. 2000 May;45(5):533-4.
8
[Effect of 16-week use of salmeterol on ECP levels, pulmonary function tests and bronchial hyperreactivity in patients with chronic obstructive lung disease].[沙美特罗16周使用对慢性阻塞性肺疾病患者嗜酸性粒细胞阳离子蛋白水平、肺功能测试及支气管高反应性的影响]
Pol Tyg Lek. 1995 Oct;50(40-44):48-9, 63.
9
[When are bronchodilator agents sufficient in asthma/chronic obstructive pulmonary disease?].[何时支气管扩张剂对哮喘/慢性阻塞性肺疾病足够有效?]
Ned Tijdschr Geneeskd. 1995 Aug 5;139(31):1580-3.
10
Predicting response to bronchodilator therapy in chronic obstructive pulmonary disease.预测慢性阻塞性肺疾病患者对支气管扩张剂治疗的反应
Arch Intern Med. 1988 Sep;148(9):1909-10.

引用本文的文献

1
Asthma clustering methods: a literature-informed application to the children's health study data.哮喘聚类方法:基于文献的儿童健康研究数据应用
J Asthma. 2022 Jul;59(7):1305-1318. doi: 10.1080/02770903.2021.1923738. Epub 2021 May 18.
2
Asthma-COPD overlap: current understanding and the utility of experimental models.哮喘-慢阻肺重叠:当前认识和实验模型的应用。
Eur Respir Rev. 2021 Feb 16;30(159). doi: 10.1183/16000617.0185-2019. Print 2021 Mar 31.
3
Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink).
英国一大群初级保健患者(临床实践研究数据链)中预定义哮喘表型的临床概况
J Asthma Allergy. 2019 Jan 8;12:7-19. doi: 10.2147/JAA.S182013. eCollection 2019.
4
A cluster analysis of chronic obstructive pulmonary disease in dusty areas cohort identified three subgroups.一项针对尘肺病队列中慢性阻塞性肺疾病的聚类分析确定了三个亚组。
BMC Pulm Med. 2017 Dec 16;17(1):209. doi: 10.1186/s12890-017-0553-9.
5
Distinct symptom experiences in subgroups of patients with COPD.慢性阻塞性肺疾病(COPD)患者亚组中不同的症状体验。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 2;11:1801-9. doi: 10.2147/COPD.S105299. eCollection 2016.
6
Wheezing, a significant clinical phenotype of COPD: experience from the Taiwan Obstructive Lung Disease Study.哮鸣,慢性阻塞性肺疾病的一种重要临床表型:来自台湾阻塞性肺病研究的经验。
Int J Chron Obstruct Pulmon Dis. 2015 Oct 7;10:2121-6. doi: 10.2147/COPD.S92062. eCollection 2015.
7
Derivation and validation of clinical phenotypes for COPD: a systematic review.慢性阻塞性肺疾病临床表型的推导与验证:一项系统评价
Respir Res. 2015 Apr 18;16(1):50. doi: 10.1186/s12931-015-0208-4.
8
Study Design and Outcomes of Korean Obstructive Lung Disease (KOLD) Cohort Study.韩国阻塞性肺病(KOLD)队列研究的研究设计与结果
Tuberc Respir Dis (Seoul). 2014 Apr;76(4):169-74. doi: 10.4046/trd.2014.76.4.169. Epub 2014 Apr 25.
9
Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease: a critical review of the literature.慢性阻塞性肺疾病患者治疗反应的生物标志物:文献综述。
Drugs. 2011 Oct 1;71(14):1821-37. doi: 10.2165/11595180-000000000-00000.